A simple stereoselective synthesis and biological evaluation of FR181157: Orally active prostacyclin mimetic

Bioorganic and Medicinal Chemistry Letters

Volumn 13, Issue 24, 2003, Pages 4277-4279

  Hattori, Kouji ^a   Tabuchi, Seiichiro ^a   Okitsu, Osamu ^a   Taniguchi, Kiyoshi ^a  

^a ASTELLAS PHARMA INC   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FR 181157; PROSTACYCLIN DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOG; DRUG ACTIVITY; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG SYNTHESIS; NONHUMAN; RAT; SHARPLESS EPOXIDATION; STEREOCHEMISTRY;

EID: 0344927115     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2003.09.054     Document Type: Article

References (23)

1. (a) Wise H., Jones R.L. TiPS. 17:1996;17
2. (b) Meanwell N.A., Romine J.L., Seiler S.M. Drugs Future. 19:1994;361
3. (c) Vane J., O'Grady J. Therapeutic Applications of Prostaglandins. 1993;Edward Arnold, London
4. (d) Dusting G.J., MacDonald P.S. Pharmacol. Ther. 48:1990;323.
5. Muir G., Jones R.L., Will S.G., Winwick T., Peesapatil V., Wilson N.H., Griffiths N., Nicholson W.V., Taylor P., Sawyer L., Blake A.J. Eur. J. Med. Chem. 28:1993;609.
6. (a) Meanwell N.A., Rosenfeld M.J., Wright J.J.K., Brassard C.L., Buchanan J.O., Federici M.E., Fleming J.S., Seiler S.M. J. Med. Chem. 35:1992;389
7. (b) Meanwell N.A., Rosenfeld M.J., Trehan A.K., Wright J.J.K., Brassard C.L., Buchanan J.O., Federici M.E., Fleming J.S., Gamberdella M., Zavoico G.B., Seiler S.M. J. Med. Chem. 35:1992;3483
8. (c) Meanwell N.A., Rosenfeld M.J., Trehan A.K., Romine J.L., Wright J.J.K., Brassard C.L., Buchanan J.O., Federici M.E., Fleming J.S., Gamberdella M., Zavoico G.B., Seiler S.M. J. Med. Chem. 35:1992;3498
9. (d) Meanwell N.A., Rosenfeld M.J., Wright J.J.K., Brassard C.L., Buchanan J.O., Federici M.E., Fleming J.S., Gamberdella M., Hartl K.S., Zavoico G.B., Seiler S.M. J. Med. Chem. 36:1993;3871
10. (e) Meanwell N.A., Romine J.F., Rosenfeld M.J., Martin S.W., Trehan A.K., Wright J.J.K., Malley M.F., Gougoutas J.Z., Brassard C.L., Buchanan J.O., Federici M.E., Fleming J.S., Gamberdella M., Hartl K.S., Zavoico G.B., Seiler S.M. J. Med. Chem. 36:1993;3884.
11. (a) Hamanaka N., Takahashi K., Nagao Y., Toritsu K., Tokumoto H., Kondo K. Bioorg. Med. Chem. Lett. 5:1995;1065
12. (b) Hamanaka N., Takahashi K., Nagao Y., Toritsu K., Takada H., Tokumoto H., Kondo K. Bioorg. Med. Chem. Lett. 5:1995;1071
13. (c) Hamanaka N., Takahashi K., Nagao Y., Toritsu K., Tokumoto H., Kondo K. Bioorg. Med. Chem. Lett. 5:1995;1077
14. (d) Hamanaka N., Takahashi K., Nagao Y., Toritsu K., Tokumoto H., Kondo K. Bioorg. Med. Chem. Lett. 5:1995;1083
15. (e) Hamanaka N., Takahashi K., Nagao Y., Toritsu K., Shigeoka S., Hamada S., Kato H., Tokumoto H., Kondo K. Bioorg. Med. Chem. Lett. 5:1995;1083.
16. (a) McNiven N.L., Read J. J. Chem. Soc. 1952;153
17. (b) Hughes E.D., Wilby J. J. Chem. Soc. 1960;4094.
18. Sharpless K.B., Amberg W., Bennani Y.L., Crispino G.A., Hartung J., Jeong K.-S., Kwong H.-L., Morikawa K., Wang Z.-M., Xu D., Zhang X.-L. J. Org. Chem. 57:1992;2768.
19. Kolb H.C., Sharpless K.B. Tetrahedron. 48:1992;10515.
20. 3, 10: δ 2.53 (1H, dd, J=10.2, 12.8 Hz), 2.31 (1H, dd, J=3.2, 12.8 Hz), 12: δ 4.09 (2H, s).
21. 2 agonist activity and high permeability of skin.
22. Katsuyama M., Sugimoto Y., Namba T., Irie A., Negishi M., Narumiya S., Ichikawa A. FEBS Lett. 344:1994;74 Boie Y., Ruchmore T.H., Darmon-Goodwin A., Grygorczyk R., Slipetz D.M., Metters K., Abramovitz M. J. Biol. Chem. 269:1994;12173.
23. Katsuyama M., Sugimoto Y., Namba T., Irie A., Negishi M., Narumiya S., Ichikawa A. FEBS Lett. 344:1994;74 Boie Y., Ruchmore T.H., Darmon-Goodwin A., Grygorczyk R., Slipetz D.M., Metters K., Abramovitz M. J. Biol. Chem. 269:1994;12173.